Dec 16th, 2022 |
15:47
Biosimilars: The logistics of switching between biosimilars or between biosimilars and reference product
Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Dr. Christina Ha. Each episode features a challenging patient case and short discussion.
In episode 3 of 4, we're joined by guests Shuba Bhat, PharmD, and Jennifer Seminerio-Diehl, MD, to discuss:
• What are the practical logistics when you work on a switch with a patient?
• How do you address a situation where a patient says they are experiencing an increase in symptoms after a switch?
• Are there any situations where you would consider appealing an insurance decision and not switching?
• What tests do you use to determine whether a patient is experiencing active disease before or after a switch?
This series is supported by independent medical education grants from Amgen and Pfizer.
To collect CME credit for listening, visit agau.gastro.org.